IVA Inventiva S.A.

Nasdaq inventivapharma.com


$ 4.11 $ -1.11 (-21.06 %)    

Wednesday, 29-Oct-2025 18:24:37 EDT
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 4.16
$ 3.80
$ 4.07 x 58
$ 4.20 x 657
$ 3.79 - $ 4.70
$ 2.11 - $ 7.98
2,897,629
na
397.96M
$ 0.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Reuters

 hc-wainwright--co-maintains-buy-on-inventiva-raises-price-target-to-24

HC Wainwright & Co. analyst Ananda Ghosh maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $2...

 canaccord-genuity-maintains-buy-on-inventiva-maintains-20-price-target

Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and maintains $20 price target.

 inventiva-moonlake-immunotherapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiv...

Core News & Articles

Companies Reporting Before The Bell • Inventiva (NASDAQ: IVA) is projected to report quarterly loss at $0.41 per share on reven...

 inventiva-h1-eps-184-misses-041-estimate-sales-5050m-miss-5310m-estimate

Inventiva (NASDAQ: IVA) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.41) b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION